%0 Journal Article
%T The efficacy and safety of Osimertinib in advanced non-small cell lung cancer patients with Thr790Met resistance mutations: a systematic review and meta-analysis
%A Cui, Saijin
%A Zhang, Yaling
%A Liu, Lu
%A Li, Yan
%A Zhou, Rongmiao
%A Huang, Xi
%A Cao, Shiru
%A Huo, Xiangran
%A Wang, Na
%J Annals of Palliative Medicine
%D 2021
%B 2021
%9 
%! The efficacy and safety of Osimertinib in advanced non-small cell lung cancer patients with Thr790Met resistance mutations: a systematic review and meta-analysis
%K 
%X 
%U https://apm.amegroups.org/article/view/60384
%V 10
%N 2
%P 1851-1860
%@ 2224-5839